Summary
One hundred forty one ASORN members representing 39 states responded to this survey. Results are given in number of respondents for each answer.
1. Since the introduction of the eye drop Restasis for chronic dry eye syndrome, have you seen a reduction in the number of established patients who had previously presented complaining of this problem without relief?
| a. | Yes |
14 |
| b. | No |
13 |
| c. | Unknown |
32 |
| d. | Not applicable to my practice |
82 |
2. If yes, were other therapies used in conjunction with Restasis?
| a. | Yes |
15 |
| b. | No |
3 |
| c. | Unknown |
24 |
| d. | Not applicable to my practice |
66 |
|
(33 respondents) |
3. My work setting is primarily
| a. | Anterior segment office |
4 |
| b. | Posterior segment office |
7 |
| c. | General ophthalmology office |
22 |
| d. | Surgery |
92 |
|
(Other write-in answers included clinic, hospital, PACU, ORBIS, retired, and combinations of the above.) | |